MACC1 and pancreatic neoplasm: The results revealed that compared with cells with MACC1-AS1 overexpression alone, siSTK33 co-transfection and STK33 inhibitors reduced the gemcitabine IC50 value in pancreatic cancer cell lines exhibiting a high expression level of MACC1-AS1 to some extent.